Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

Domestic Biomanufacturing Expansion: Bristol Myers Squibb Commits $2.3 Billion to Build High-Tech Manufacturing Campus in Houston, Texas

11/08/2026 Published by Pharma Biz

Key Development American biopharmaceutical leader Bristol Myers Squibb (NYSE: BMY) has officially announced a $2.3 billion investment to construct a... Read more

Tags: #Global Trends

Greater China Commercial Expansion: Innovent Biologics and Daiichi Sankyo Sign Exclusive Commercialization Agreement for Vanflyta® in China

11/08/2026 Published by Pharma Biz

Key Development Biopharmaceutical major Innovent Biologics, Inc. (HKEX: 1801) and Japanese pharmaceutical company Daiichi Sankyo Company, Limited (TSE: 4568) have... Read more

Category: Uncategorized

Tags: #Global Trends

Rare Oncology Licensing Agreement: Sobi Secures Global Rights to Innate Pharma’s Lacutamab in Up to $580 Million Deal Targeting Cutaneous T-Cell Lymphoma (CTCL)

11/08/2026 Published by Pharma Biz

Key Development Swedish rare disease specialist Swedish Orphan Biovitrum (Sobi) has executed an exclusive global licensing agreement valued at up... Read more

Category: Uncategorized

Tags: #Global Trends

Biopharma AI Convergence: Novo Nordisk and Amazon Web Services (AWS) Form Strategic AI Drug Discovery Pact, Launching London Innovation Hub

11/08/2026 Published by Pharma Biz

Key Development Danish biopharmaceutical major Novo Nordisk (OMX: NOVOb) and Amazon Web Services (AWS)—the cloud computing division of Amazon.com—have formally... Read more

Category: Uncategorized

Tags: #Global Trends

Targeted Radiopharmaceuticals & Rare Epilepsy M&A: Jazz Pharmaceuticals Executes $1.32 Billion Acquisition of Actio Biosciences to Acquire First-in-Class Pediatric Precision Therapy

11/08/2026 Published by Pharma Biz

Key Development Biopharmaceutical major Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has entered into a definitive agreement to acquire privately held biotechnology... Read more

Category: Uncategorized

Tags: #M&A

Counterfeit Eastern Medicine Syndicate Dismantled: Phu Tho Provincial Police Prosecute 21 Defendants in “Xuong Khop Ba Sau” Fraudulent Healthcare Advertising Case

11/08/2026 Published by Pharma Biz

Key Development The Investigative Police Agency of Phu Tho Provincial Police has officially initiated criminal proceedings, indicting 21 defendants on... Read more

Category: Uncategorized

Tags: #Vietnam

Traditional Medicine Regulatory Enforcement: Ministry of Health Issues Urgent Directive Inspecting Illicit Herbal Medicine Sales at Tourist Sites and Digital Fraud

11/08/2026 Published by Pharma Biz

Key Development On August 10, 2026, the Ministry of Health (MOH) of Vietnam issued an urgent regulatory directive to the... Read more

Category: Uncategorized

Tags: #Vietnam

Biopharmaceutical M&A: Biogen Completes Acquisition of RayThera Inc., Expanding Immunology Pipeline with Small-Molecule Assets

10/08/2026 Published by Pharma Biz

Key Development American biotechnology major Biogen Inc. (NASDAQ: BIIB) officially announced the completion of its acquisition of RayThera Inc., a... Read more

Category: Uncategorized

Tags: #M&A

Cross-Border Food Safety Crisis: Taylor Farms Issues Voluntary Recall of Salsa and Guacamole Formulations Over Imported Jalapeño Salmonella Risk

10/08/2026 Published by Pharma Biz

Key Development Leading U.S. produce processor Taylor Farms (headquartered in Salinas, California) has officially initiated a voluntary recall covering multiple... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 15 Page 16 Page 17 … Page 200 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members